325 results on '"Guilpain, Philippe"'
Search Results
2. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes
3. High prevalence of malnutrition in systemic sclerosis: Results from a French monocentric cross-sectional study
4. Long-term home parenteral nutrition in systemic sclerosis-related intestinal failure is feasible but unveils occult cardiac disease
5. Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms
6. Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study
7. Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis
8. Sjögren syndrome overlapping with ANCA-associated vasculitis: Four additional cases and systematic literature review
9. Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C‐finding treated with midostaurin.
10. The interplay between cognition, depression, anxiety, and sleep in primary Sjogren’s syndrome patients
11. Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey
12. Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database
13. Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p
14. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
15. Comorbidities and health-related quality of life in Patients with Antineutrophil Cytoplasmic Antibody (ANCA) - associated vasculitis
16. Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients
17. Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study
18. Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review
19. Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory disease
20. Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry
21. The CARMEN-France registry of adult patients with immune thrombocytopenia and autoimmune hemolytic anemia in France
22. Clinical and microbiological characteristics of the infections in patients treated with rituximab for autoimmune and/or malignant hematological disorders
23. Childhood- versus adult-onset ANCA-associated vasculitides: A nested, matched case–control study from the French Vasculitis Study Group Registry
24. In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case–control study
25. ANCA positivity and the limited expression of vasculitides
26. P1613: REAL-WORLD USE OF FOSTAMATINIB IN FRANCE. INTERIM RESULTS OF A NATIONAL REGISTRY.
27. Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients
28. Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry.
29. Two neurologic facets of CTLA4-related haploinsufficiency
30. Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series
31. Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis
32. Clinical, Radiologic, and Immunologic Features of Patients With CTLA4 Deficiency With Neurologic Involvement.
33. Emerging clinical phenotypes associated with anti-cytokine autoantibodies
34. Hospitalizations for infections in primary Sjögren’s syndrome patients: a nationwide incidence study
35. Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis
36. Mastitis associated with Sjögren’s syndrome: a series of nine cases
37. Immune‐mediated diseases involving central and peripheral nervous systems
38. JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use
39. Characteristics, outcome and treatments with cranial pachymeningitis: A multicenter French retrospective study of 60 patients
40. Hospitalizations for infections in primary Sjögren’s syndrome patients: a nationwide incidence study
41. Anti-NXP2 antibody-associated extensive subcutaneous calcinosis in adult-onset myositis
42. Glomérulonéphrite membrano-proliférative post-grippale chez un patient atteint de mastocytose systémique agressive : observation commentée et revue de la littérature
43. Patients’ Baseline Characteristics, but Not Tocilizumab Exposure, Affect Severe Outcomes Onset in Giant Cell Arteritis: A Real-World Study
44. Hospitalization Risks for Neurological Disorders in Primary Sjögren’s Syndrome Patients
45. Maladies neuro-inflammatoires centrales par haplo-insuffisance héréditaire en CTLA4
46. Cancer-associated systemic sclerosis in a Canadian cohort: beyond strengths and weaknesses of epidemiological studies
47. Lung Fibrosis Is Improved by Extracellular Vesicles from IFNγ-Primed Mesenchymal Stromal Cells in Murine Systemic Sclerosis
48. Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis
49. Immune‐mediated diseases involving central and peripheral nervous systems.
50. French recommendations for the management of systemic sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.